对质瘤流行病学和治疗方法的分析见解
Meichen Ji1, Dan Tian1, Qing Qi2
1Department of Oncology, Heyuan People's Hospital, Guangdong Provincial People's Hospital Heyuan Hospital, Heyuan 517000, Guangdong, China; Heyuan Key Laboratory of Molecular Diagnosis & Disease Prevention and Treatment, Doctors Station of Guangdong province, Heyuan People's Hospital, Heyuan, Guangdong, China.
World neurosurgery
|December 28, 2025
概括
质瘤的发病率正在下降,但生存率正在提高. 手术和化疗等治疗策略,以及IDH突变等因素,显著影响质瘤患者的结果和预后.
科学领域:
- 神经瘤学神经瘤学
- 流行病学 流行病学
- 癌症研究 癌症研究
背景情况:
- 质瘤是内恶性瘤的一种流行和积极的形式.
- 了解流行病学特征和治疗影响对于质母细胞瘤风险和生存至关重要.
- 这项研究检查了年龄,性别,种族和收入与质瘤发展和结果的关系.
研究的目的:
- 分析质瘤发生率和生存趋势.
- 调查流行病学因素对质瘤风险的影响.
- 评估各种治疗策略对患者生存的有效性.
主要方法:
- 利用了来自监测,流行病学和最终结果 (SEER) 数据库的44778名质瘤患者 (1980-2019) 的数据.
- 采用卡普兰-梅尔方法进行生存曲线分析.
- 进行了考克斯回归分析,以确定预后因素.
主要成果:
- 整体上,质瘤发病率呈下降趋势,白人,男性和60岁以上的人群的发病率更高.
- 在所有子组中,生存率逐渐增加.
- 对于1-2级质瘤来说,手术是最佳的;对于3-4级质瘤来说,手术后的化疗改善了结果. 化疗和IDH突变是保护因素,而3-4级瘤和50岁以上的年龄是危险因素. 化学放射治疗的手术对IDH突变和/或1p/19q代选择的患者最有效.
结论:
- 质瘤发病率模式是动态的,存活率的持续改善.
- 分子特征 (IDH突变,1p/19q代选择) 和社会经济因素显著影响预后.
- 这些发现支持改进结质瘤的临床诊断和治疗策略.
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:25Statistical Methods for Analyzing Epidemiological Data
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...